Skip to main content
OpenTrials

Clinical trial condition

Brain Neoplasms

Explore clinical trials studying Brain Neoplasms. Study availability and eligibility vary by location and protocol.

1,677 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Brain Neoplasms trial results

Active, Not Recruiting

Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis

NCT04074096

Conditions
BRAF V600 Mutation, Brain Diseases, Brain Metastases, +18 more
Locations
  • APHP - Hôpital Avicenne Bobigny, France
  • CHU de Bordeaux - Hôpital Saint André Bordeaux, France
  • GH Sud CHU Bordeaux - Hôpital Levêque Bordeaux, France
  • APHP - Hôpital Ambroise Paré Boulogne-Billancourt, France
View all 21 locations
View Trial Details
Active, Not Recruiting

Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

NCT04690348

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +6 more
Locations
  • Baptist Health South Florida Miami, Florida, United States
  • Memorial Sloan Kettering at Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent Only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

NCT02429570

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +7 more
Locations
  • Baptist Health South Florida Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details

Related conditions